Automated system for polynucleotide synthesis and purification
First Claim
1. A method for purifying a polynucleotide comprising(a) forming a polynucleotide on a solid support by repeated steps of (i) deblocking a 5′
- -hydroxyl group of a 5′
-blocked protected nucleoside having a 3′
-hydroxyl and a 5′
-hydroxyl, (ii) reacting the deblocked 5′
-hydroxyl with a 5′
-blocked protected nucleoside monomer selected from the group consisting of 5′
-blocked protected nucleoside-3′
-phosphoramidite and 5′
-blocked protected nucleoside-3′
-hydrogen phosphonate to form either a protected correct-sequence polynucleotide chain or a failure sequence, the failure sequence having a 5′
-hydroxyl, and (iii) repeating steps (i) and (ii) until a desired polynucleotide is obtained, wherein the solid support comprises a chamber containing (1) a nonswellable porous polystyrene support capable of remaining substantially mechanically rigid during polynucleotide synthesis, and (2) a hydrophobic adsorbent capable of non-covalently adsorbing a tritylated polynucleotide, (b) cleaving the polynucleotide from the nonswellable porous polystyrene support to form a cleavage mixture, (c) purifying the cleaved polynucleotide from the cleavage mixture by adsorbing the cleaved polynucleotide to the hydrophobic adsorbent and washing the hydrophobic adsorbent to selectively remove unblocked polynucleotides which the cleaved polynucleotide, and (d) deblocking the 5′
-hydroxyl of the adsorbed polynucleotide to form a deblocked polynucleotide and eluting the deblocked polynucleotide from the hydrophobic adsorbent.
6 Assignments
0 Petitions
Accused Products
Abstract
A method and system for polynucleotide synthesis are provided which employ solid phase synthesis on a nonswellable porous polystyrene support by phosphoramidite or hydrogen phosphonate chemistries. The polystyrene support gives rise to fewer tritylated failure sequences caused by chain growth from extraneous support sites, and allows lower amounts of monomer reactants to be used to achieve equal or better coupling efficiencies as those achieveable with CPG. The method and system also employ nucleoside intermediates whose exocyclic amines are protected by base-labile groups which permit simultaneous cleavage and deprotection of the completed polynucleotide chain in the presence of the solid phase support. This latter feature allows practical automation of both the synthesis and purification of polynucleotides.
19 Citations
12 Claims
-
1. A method for purifying a polynucleotide comprising
(a) forming a polynucleotide on a solid support by repeated steps of (i) deblocking a 5′ - -hydroxyl group of a 5′
-blocked protected nucleoside having a 3′
-hydroxyl and a 5′
-hydroxyl, (ii) reacting the deblocked 5′
-hydroxyl with a 5′
-blocked protected nucleoside monomer selected from the group consisting of 5′
-blocked protected nucleoside-3′
-phosphoramidite and 5′
-blocked protected nucleoside-3′
-hydrogen phosphonate to form either a protected correct-sequence polynucleotide chain or a failure sequence, the failure sequence having a 5′
-hydroxyl, and (iii) repeating steps (i) and (ii) until a desired polynucleotide is obtained, wherein the solid support comprises a chamber containing (1) a nonswellable porous polystyrene support capable of remaining substantially mechanically rigid during polynucleotide synthesis, and (2) a hydrophobic adsorbent capable of non-covalently adsorbing a tritylated polynucleotide,(b) cleaving the polynucleotide from the nonswellable porous polystyrene support to form a cleavage mixture, (c) purifying the cleaved polynucleotide from the cleavage mixture by adsorbing the cleaved polynucleotide to the hydrophobic adsorbent and washing the hydrophobic adsorbent to selectively remove unblocked polynucleotides which the cleaved polynucleotide, and (d) deblocking the 5′
-hydroxyl of the adsorbed polynucleotide to form a deblocked polynucleotide and eluting the deblocked polynucleotide from the hydrophobic adsorbent.- View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12)
wherein R1 is hydrogen or lower alkyl, R2 is hydrogen, lower alkyl, lower alkoxy, lower aryloxy, or cyano-, nitro-, or sulfono-substituted lower aryloxy, R′
is methyl or beta-cyanoethyl, DMT is dimethoxytrityl, and B is adenine, guanine, thymidine, or cytidine.
- -hydroxyl group of a 5′
-
6. The method of claim 5 wherein R1 is hydrogen, ethyl, or propyl, and R2 is hydrogen, methyl, ethyl, propyl, methoxy, ethoxy, isopropoxy, tert-butyloxy, phenoxy, napthoxy, or biphenoxy.
-
7. The method of claim 6 wherein R1 is hydrogen or methyl, and R2 is hydrogen, methyl, ethoxy, or phenoxy.
-
8. The method of claim 1 wherein said step of reacting further includes exposing said 5′
- -hydroxyl of said correct-sequence chain to said 5′
-blocked protected nucleoside monomer, said 5′
-blocked protected nucleoside monomer being in less than or equal to ten molar excess of said 5′
-hydroxyl of said correct-sequence chain.
- -hydroxyl of said correct-sequence chain to said 5′
-
9. The method of claim 8 wherein said 5′
- -blocked protected nucleoside monomer is a 5′
-blocked protected nucleoside-3′
-phosphoramidite.
- -blocked protected nucleoside monomer is a 5′
-
10. The method of claim 1, wherein said hydrophobic adsorbent is a nonswellable porous polystyrene adsorbent.
-
11. The method of claim 1 wherein said 5′
- -blocked protected nucleoside monomer is a 5′
-blocked protected nucleoside-3′
-hydrogen phosphonate.
- -blocked protected nucleoside monomer is a 5′
-
12. The method of claim 1 wherein said 5′
- -blocked protected nucleoside monomer is a 5′
-blocked protected nucleoside-3′
-phosphorarnidite.
- -blocked protected nucleoside monomer is a 5′
Specification